Zepbound is FDA-approved along with regular exercise and a reduced-calorie diet for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m 2 or higher (obesity) 27 kg/m 2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea Tirzepatide is the active ingredient in Zepbound
Pioglitazone, a diabetes medication, may benefit selected patients with biopsy-proven NASH, but is also specialist-led and off-label , with potential risks including weight gain, fluid retention, heart failure, and increased fracture risk
For those interested in exploring tirzepatide treatment, telehealth platforms such as Doctronic.ai offer a convenient way to consult with healthcare providers
On the other hand, different peptides can elicit various side effects based on their structure and functions